tiprankstipranks
CervoMed price target lowered to $4 from $45 at Roth MKM
PremiumThe FlyCervoMed price target lowered to $4 from $45 at Roth MKM
2M ago
CervoMed price target lowered to $12 from $65 at Canaccord
Premium
The Fly
CervoMed price target lowered to $12 from $65 at Canaccord
2M ago
CervoMed downgraded to Underweight from Overweight at Morgan Stanley
Premium
The Fly
CervoMed downgraded to Underweight from Overweight at Morgan Stanley
2M ago
CervoMed Faces Setback in Phase 2b Trial
PremiumCompany AnnouncementsCervoMed Faces Setback in Phase 2b Trial
2M ago
CervoMed announces RewinD-LB Phase 2b did not meet primary endpoint
Premium
The Fly
CervoMed announces RewinD-LB Phase 2b did not meet primary endpoint
2M ago
CervoMed initiated with Buy into ‘binary readout’ at Roth MKM
Premium
The Fly
CervoMed initiated with Buy into ‘binary readout’ at Roth MKM
3M ago
CervoMed initiated with a Buy at D. Boral Capital
PremiumThe FlyCervoMed initiated with a Buy at D. Boral Capital
3M ago
CervoMed appoints Ordonez, Rosch as SVPs
Premium
The Fly
CervoMed appoints Ordonez, Rosch as SVPs
3M ago
CervoMed Inc. Reports Increased R&D Expenses Amid Ongoing Trials
Premium
Company Announcements
CervoMed Inc. Reports Increased R&D Expenses Amid Ongoing Trials
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100